ASTRALIS ANNOUNCES COMPLETION OF $2.0 MILLION PRIVATE PLACEMENT

Astralis Ltd (OTC Bulletin Board: ASTR News) announced today the completion of a private placement of $2.0 million in common stock and warrants with Blue Cedar, Ltd. A second closing of this current round with additional institutional investors is expected in September. The closing price for the placement was $0.11 per share. Astralis intends to use the proceeds of the financing to support the return of Psoraxine, its product for the treatment of psoriasis, to clinical testing.

Yahoo News (http://biz.yahoo.com/prnews/050819/laf002.html?.v=18)